IL71274A - Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciffrol - Google Patents

Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciffrol

Info

Publication number
IL71274A
IL71274A IL71274A IL7127484A IL71274A IL 71274 A IL71274 A IL 71274A IL 71274 A IL71274 A IL 71274A IL 7127484 A IL7127484 A IL 7127484A IL 71274 A IL71274 A IL 71274A
Authority
IL
Israel
Prior art keywords
dihydroxyergocalciffrol
1alpha
intermediates
preparation
Prior art date
Application number
IL71274A
Other languages
English (en)
Other versions
IL71274A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL71274A0 publication Critical patent/IL71274A0/xx
Publication of IL71274A publication Critical patent/IL71274A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL71274A 1983-03-21 1984-03-19 Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciffrol IL71274A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/477,059 US4508651A (en) 1983-03-21 1983-03-21 Synthesis of 1α,25-dihydroxyergocalciferol

Publications (2)

Publication Number Publication Date
IL71274A0 IL71274A0 (en) 1984-06-29
IL71274A true IL71274A (en) 1988-03-31

Family

ID=23894350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71274A IL71274A (en) 1983-03-21 1984-03-19 Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciffrol

Country Status (7)

Country Link
US (1) US4508651A (xx)
EP (1) EP0122490A3 (xx)
JP (1) JPS59176250A (xx)
AU (1) AU2593784A (xx)
DK (1) DK159384A (xx)
IL (1) IL71274A (xx)
ZA (1) ZA842028B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003299A1 (en) * 1984-01-30 1985-08-01 Wisconsin Alumni Research Foundation Side-chain unsaturated 1-hydroxyvitamin d compounds
DE3590080C2 (xx) * 1984-03-05 1992-08-06 Wisconsin Alumni Research Foundation, Madison, Wis., Us
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
CH672920A5 (xx) * 1984-10-04 1990-01-15 Wisconsin Alumni Res Found
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
WO1986004333A1 (en) * 1985-01-17 1986-07-31 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
JPS62501505A (ja) * 1985-01-17 1987-06-18 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン ビタミンｄ誘導体
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US5247123A (en) * 1987-09-14 1993-09-21 Hoffmann-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
US4898855A (en) * 1987-09-14 1990-02-06 Hoffman-La Roche Inc. Deuterated analogs of 1,25-dihydroxycholecalciferol
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
EP0521550B1 (en) * 1991-07-05 1996-09-18 Duphar International Research B.V Vitamin D compound, method of preparing this compound and intermediate therefor
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
JP2001511811A (ja) * 1997-02-13 2001-08-14 ボーン ケア インターナショナル インコーポレイテッド ビタミンｄ化合物の標的治療放出
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
WO2007105773A1 (ja) * 2006-03-15 2007-09-20 Mercian Corporation インデン誘導体の製造方法およびその製造中間体
CA2684778C (en) * 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process

Also Published As

Publication number Publication date
JPS59176250A (ja) 1984-10-05
US4508651A (en) 1985-04-02
IL71274A0 (en) 1984-06-29
EP0122490A2 (de) 1984-10-24
AU2593784A (en) 1984-09-27
EP0122490A3 (de) 1985-11-06
ZA842028B (en) 1984-12-24
DK159384A (da) 1984-09-22
DK159384D0 (da) 1984-03-19

Similar Documents

Publication Publication Date Title
IL71274A0 (en) Process and intermediates for the preparation of 1alpha,25-dihydroxyergocalciferol
DE3569375D1 (en) Process for the preparation of 1,2-benzisothiazolones
PT81526A (en) Process for the preparation of new homopropargylamines
EP0113568A3 (en) Intermediates for the preparation of ceftazidine, and process for their preparation
GR80204B (en) Process for the preparation of 16-fluoro-16,17-didehydro prostanoids
IL71446A (en) Process for the preparation of 1,8-dihydroxy-10-alkanoyl-9-anthrones
IL80305A (en) Process for the preparation of ypsilon-butyrolactams and some novel intermediates
DE3563351D1 (en) Process for the preparation of tetrachloro-benzo-1,4-dioxenes
IL77661A (en) Process for the preparation of 4,4-azetidinones,and novel intermediates thereof
PT81187A (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
DE3465083D1 (en) Process of preparation of 2-substituted-5-nitroso-4,6-diamino-pyrimidines
PT79823A (en) Process for the preparation of n-(naphtyl-alquil)-hydroxilamines
PT83799A (en) Process for the preparation of novel 2,2:-bi-1h-imidazoles
IL76243A (en) Process and intermediates for the preparation of aromatic-1,4-oxazepinones and-thiones
DE3369132D1 (en) Process for the preparation of isomelamines, and their use
EP0093485A3 (en) Process for the preparation of substituted 3-oxa-1-aza-bicyclo(4.2.0)octan-8-ones, and intermediates obtained thereby
PT85023A (en) Process for the preparation of substituted 2-phenylacetil-1,3,5-cyclohexanetriones and of intermediates
EP0198795A3 (en) Process for the preparation of 1,4-diaminoanthraquinones
DE3660597D1 (en) Process for the preparation of 5-fluorotoluene-2,4-disulfochloride
DE3364377D1 (en) Dialkoxymethyl-butyrolactone, process and intermediates for their preparation and their use
EP0195738A3 (en) Process for the preparation of n,n -diisopropyl-2-benzothiazyl-sulfenamide
PT83637A (en) Process for the preparation of antidepressant 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3-thiones
EP0161548A3 (en) Process for the preparation of riboflavin, and intermediates for this process
DE3375782D1 (en) Process for the preparation of compounds of the megastigman-series, and intermediates for this synthesis
DE3662784D1 (en) Process for the preparation of 1,3,6,8-tetrabromopyrene

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees